ATNM
Actinium Pharmaceuticals Inc
NYSE MKT: ATNM · HEALTHCARE · BIOTECHNOLOGY
$1.12
-4.70% today
Updated 2026-04-30
Market cap
$40.16M
P/E ratio
—
P/S ratio
446.22x
EPS (TTM)
$-1.09
Dividend yield
—
52W range
$1 – $2
Volume
0.2M
Actinium Pharmaceuticals Inc (ATNM) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $622000.00 | $1.14M | $1.03M | $81000.00 | $0.00 | $90000.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | +83.9% | -10.0% | -92.1% | -100.0% | — |
| Cost of revenue | — | — | — | — | — | — | — | $4122.00 | $0.00 | $53465.00 | $77523.00 | $55938.00 | $50721.00 | $420089.00 | $447000.00 | $524000.00 | $699000.00 | $790000.00 | $811000.00 | — |
| Gross profit | — | — | — | — | — | — | — | $-4122.00 | $0.00 | $-53465.00 | $-77523.00 | $-55938.00 | $-50721.00 | $-420089.00 | $-447000.00 | $620000.00 | $1.03M | $81000.00 | $-811000.00 | $90000.00 |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -71.9% | 54.2% | 100.0% | 100.0% | — | 100.0% |
| R&D | — | — | — | — | — | — | $3.44M | $2.67M | $12.27M | $13.31M | $17.50M | $17.70M | $17.09M | $16.55M | $16.09M | $17.51M | $23.14M | $38.67M | $30.05M | $21.12M |
| SG&A | $17534.00 | $11011.00 | $18916.00 | $14535.00 | $25405.00 | $9615.00 | $4.51M | $3.92M | $10.18M | $11.46M | $9.27M | $9.15M | $6.73M | $5.52M | $6.31M | $8.08M | $12.00M | $13.33M | $12.08M | $15.21M |
| Operating income | $-17534.00 | $-11993.00 | $-26419.00 | $-16025.00 | $-26053.00 | $-9952.00 | $-7.95M | $-6.59M | $-22.48M | $-24.83M | $-26.85M | $-26.91M | $-23.83M | $-22.07M | $-22.39M | $-24.96M | $-34.10M | $-51.92M | $-42.12M | $-36.25M |
| Operating margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -3600.2% | -2182.2% | -3311.1% | -64098.8% | — | -40274.4% |
| EBITDA | $-17534.00 | $-11993.00 | $-26419.00 | $-14535.00 | $8295.00 | $15048.00 | $-7.95M | $-6.59M | $-22.44M | $-24.78M | $-26.77M | $-26.86M | $-23.78M | $-21.48M | $-21.77M | $-24.25M | $-33.41M | $-51.13M | $-37.43M | $-35.43M |
| EBITDA margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -3499.7% | -2119.8% | -3243.2% | -63123.5% | — | -39362.2% |
| EBIT | $-17534.00 | $-11993.00 | $-26419.00 | $-16025.00 | $7647.00 | $14711.00 | $-7.95M | $-6.59M | $-22.48M | $-24.83M | $-26.85M | $-26.91M | $-23.83M | $-21.90M | $-22.21M | $-24.77M | $-34.10M | $-51.92M | $-38.24M | $-36.25M |
| Interest expense | $870.00 | $2807.00 | $4824.00 | $6402.00 | $6621.00 | $4759.00 | $1.10M | $2508.00 | $866.00 | $7868.00 | $5007.00 | $5430.00 | $173359.00 | $0.00 | $0.00 | $190000.00 | $1.09M | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-18404.00 | $-14800.00 | $-31243.00 | $-22331.00 | $1674.00 | $10289.00 | $-8.36M | $-10.77M | $-24.69M | $-21.02M | $-24.32M | $-26.60M | $-23.65M | $-21.90M | $-22.21M | $-24.77M | $-33.02M | $-48.82M | $-38.24M | $-33.89M |
| Net income growth (YoY) | — | +19.6% | -111.1% | +28.5% | +107.5% | +514.6% | -81361.5% | -28.9% | -129.1% | +14.8% | -15.7% | -9.4% | +11.1% | +7.4% | -1.4% | -11.5% | -33.3% | -47.9% | +21.7% | +11.4% |
| Profit margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -3571.5% | -2165.6% | -3205.5% | -60269.1% | — | -37652.2% |